↓ Skip to main content

Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects

Overview of attention for article published in Drug Design, Development and Therapy, April 2016
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
63 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects
Published in
Drug Design, Development and Therapy, April 2016
DOI 10.2147/dddt.s102459
Pubmed ID
Authors

Su-jin Rhee, SeungHwan Lee, Seo Hyun Yoon, Joo-Youn Cho, In-Jin Jang, Kyung-Sang Yu

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 63 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 14%
Professor 7 11%
Researcher 6 10%
Lecturer 4 6%
Other 4 6%
Other 14 22%
Unknown 19 30%
Readers by discipline Count As %
Medicine and Dentistry 10 16%
Nursing and Health Professions 10 16%
Pharmacology, Toxicology and Pharmaceutical Science 7 11%
Agricultural and Biological Sciences 6 10%
Biochemistry, Genetics and Molecular Biology 4 6%
Other 6 10%
Unknown 20 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 February 2024.
All research outputs
#9,017,930
of 26,589,077 outputs
Outputs from Drug Design, Development and Therapy
#682
of 2,308 outputs
Outputs of similar age
#117,086
of 316,730 outputs
Outputs of similar age from Drug Design, Development and Therapy
#20
of 77 outputs
Altmetric has tracked 26,589,077 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,308 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 316,730 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 77 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.